Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Roshandel, Elham  [Clear All Filters]
2023
Bakhtiyaridovvombaygi M, Yazdanparast S, Mikanik F, Izadpanah A, Parkhideh S, Ghasabeh AShahbaz, Roshandel E, Hajifathali A, Gharehbaghian A. Cytokine-Induced Memory-Like NK Cells: Emerging strategy for AML immunotherapy. Biomed Pharmacother. 2023;168:115718.
Ghasemi M, Roshandel E, Mohammadian M, Farhadihosseinabadi B, Akbarzadehlaleh P, Shamsasenjan K. Mesenchymal stromal cell-derived secretome-based therapy for neurodegenerative diseases: overview of clinical trials. Stem Cell Res Ther. 2023;14(1):122.
Hajifathali A, Lasemi MVahdat, Mehravar M, Moshari MReza, Alizadeh AMohammad, Roshandel E. Novelty in improvement of CAR T cell-based immunotherapy with the aid of CRISPR system. Hematol Transfus Cell Ther. 2023.
Jalili A, Hajifathali A, Mohammadian M, Sankanian G, Sayahinouri M, Ghorbi MDehghani, Roshandel E, Aghdami N. Virus-Specific T Cells: Promising Adoptive T Cell Therapy Against Infectious Diseases Following Hematopoietic Stem Cell Transplantation. Adv Pharm Bull. 2023;13(3):469-482.
2022
Hamidpour M, Roshandel E, Nazari HGhaffari, Sankanian G, Bonakchi H, Salimi M, Salari S. Association Between Human Leukocyte Antigens and Graft-Versus-Host Disease Occurrence in Allogeneic Hematopoietic Stem Cell Transplantation - A 10-Year Experience on Iranian Patients. Arch Iran Med. 2022;25(12):798-806.
Mirfakhraie R, Ardakani MTavakoli, Hajifathali A, Karami S, Moshari MReza, Hasani M, Firouz SMashayekhi, Roshandel E. Highlighting the interaction between immunomodulatory properties of mesenchymal stem cells and signaling pathways contribute to Graft Versus Host Disease management. Transpl Immunol. 2022:101524.
Roshandel E, Ghaffari-Nazari H, Mohammadian M, Salimi M, Abroun S, Mirfakhraie R, Hajifathali A. NK cell therapy in relapsed refractory multiple myeloma. Clin Immunol. 2022;246:109168.
Nikoonezhad M, Lasemi MVahdat, Alamdari S, Mohammadian M, Tabarraee M, Ghadyani M, Hamidpour M, Roshandel E. Treatment of insulin-dependent diabetes by hematopoietic stem cell transplantation. Transpl Immunol. 2022:101682.
2021
Mirfakhraie R, Noorazar L, Mohammadian M, Hajifathali A, Gholizadeh M, Salimi M, Sankanian G, Roshandel E, Mehdizadeh M. Treatment Failure in Acute Myeloid Leukemia: Focus on the Role of Extracellular Vesicles. Leuk Res. 2021;112:106751.
2020
Mehravar M, Roshandel E, Salimi M, Chegeni R, Gholizadeh M, Mohammadi MHossein, Hajifathali A. Utilization of CRISPR/Cas9 gene editing in cellular therapies for lymphoid malignancies. Immunol Lett. 2020.
2019
Salehnasab C, Hajifathali A, Asadi F, Roshandel E, Kazemi A, Roshanpoor A. Machine Learning Classification Algorithms to Predict aGvHD following Allo-HSCT: A Systematic Review. Methods Inf Med. 2019;58(6):205-212.